AtriCure, Inc.
Clinical trials sponsored by AtriCure, Inc., explained in plain language.
A medical device company focused on surgical ablation for atrial fibrillation.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hybrid heart procedure aims to tame stubborn AFib Results expected Jan 2027 (estimated)
- New registry to reveal if heart ablation helps POTS and IST patients Results expected Jan 2027 (estimated)
- Heart surgery upgrade: new device combo aims to stop AFib before it starts Results expected Feb 2027 (estimated)
- New heart procedure aims to tame racing heartbeat without drugs Results expected Feb 2027 (estimated)
-
New hybrid heart procedure aims to tame stubborn AFib
Disease control OngoingThis study looks at a procedure called hybrid convergent ablation for people with a long-lasting type of irregular heartbeat (atrial fibrillation) that hasn't improved with medication. The procedure uses heat energy to destroy heart tissue causing the problem, combining a small c…
Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart pouch closure during surgery may slash stroke risk
Prevention OngoingThis study tests whether closing a small pouch in the heart (the left atrial appendage) during heart surgery can prevent strokes and blood clots. About 6,500 adults at risk for atrial fibrillation and stroke are taking part. The goal is to see if this simple addition to surgery i…
Sponsor: AtriCure, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New heart procedure aims to tame racing heartbeat without drugs
Symptom relief OngoingThis study tests a hybrid surgical ablation procedure for people with inappropriate sinus tachycardia (IST), a condition where the heart beats too fast without a clear cause. The procedure uses a device to carefully target heart tissue while sparing the sinus node. Researchers wa…
Sponsor: AtriCure, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC